Xdemvy (lifitegrast ophthalmic solution) 5% is a prescription eye drop approved for the treatment of the signs and symptoms of dry eye disease [1]. While marketed under the brand name Xiidra, the unbranded version is known as lifitegrast [2].
What is Xdemvy prescribed for?
Xdemvy is indicated for the treatment of the signs and symptoms of dry eye disease. It works by reducing inflammation that can cause dry eye [1].
How does Xdemvy work?
Lifitegrast is a lymphocyte function-associated antigen-1 (LFA-1) antagonist [1]. It binds to LFA-1, a protein on the surface of T-cells, and blocks the interaction of LFA-1 with its cognate ligand, intercellular adhesion molecule-1 (ICAM-1) [1]. ICAM-1 is thought to be elevated in the ocular surface tissues of people with dry eye disease. This interaction is believed to reduce T-cell mediated inflammation, a factor in dry eye disease [1].
What is the difference between Xiidra and Xdemvy?
Xiidra is the brand name under which lifitegrast ophthalmic solution is marketed. Xdemvy is also lifitegrast ophthalmic solution 5%, and is essentially the unbranded version or a specific formulation that may be referenced in commercial contexts [2].
How is Xdemvy administered?
Xdemvy is administered as one drop in each eye twice daily, approximately 12 hours apart [1].
What are the potential side effects of Xdemvy?
The most common side effects of Xdemvy include eye irritation, discomfort, blurred vision, and altered taste sensation [1].
When was Xdemvy approved and what is its patent status?
Lifitegrast was approved by the U.S. Food and Drug Administration (FDA) in July 2016 [1]. Information regarding specific patent expiry dates for Xdemvy and its active ingredient, lifitegrast, can be found through resources like DrugPatentWatch.com [3].
Who manufactures Xdemvy?
Xiidra, which is lifitegrast, was originally developed by Shire, and later acquired by Takeda Pharmaceutical Company [4].
What clinical data supports Xdemvy's efficacy?
Clinical trials have demonstrated that Xdemvy can significantly reduce the signs and symptoms of dry eye disease. Studies have shown improvements in both ocular surface staining and patient-reported symptoms [1].
Are there alternatives to Xdemvy for dry eye disease?
Other treatments for dry eye disease include artificial tears, prescription eye drops such as cyclosporine (Restasis), and various lifestyle modifications or procedures [5]. The choice of treatment depends on the individual's specific condition and severity.